Indoco Remedies secures final ANDA approval for Brivaracetam Oral Solution from USFDA

24 Feb 2026 Evaluate

Indoco Remedies has secured final Abbreviated New Drug Application (ANDA) approval from United States Food and Drug Administration (USFDA) to market its ANDA for Brivaracetam Oral Solution, 10 mg/mL. Brivaracetam Oral Solution, 10 mg/mL, have been determined to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Briviact 10 mg/mL of UCB, Inc. Brivaracetam Oral Solution will be manufactured by the company at its manufacturing facility located at Verna, Goa. 

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

164.85 -8.80 (-5.07%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×